These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 28422420

  • 21. Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.
    Kawano N, Kuriyama T, Yoshida S, Yamashita K, Ochiai H, Nakazaki S, Tasaki A, Ueda A.
    Intern Med; 2013; 52(1):55-62. PubMed ID: 23291674
    [Abstract] [Full Text] [Related]

  • 22. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
    Matsushita T, Watanabe J, Honda G, Mimuro J, Takahashi H, Tsuji H, Eguchi Y, Kitajima I, Sakata Y.
    Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
    [Abstract] [Full Text] [Related]

  • 23. Occlusion of the carotid artery as presenting symptom of acute promyelocytic leukemia.
    Delodovici M, Chelazzi G, Dario A, Castelli F, Crivelli G, Dorizzi A.
    Schweiz Arch Neurol Psychiatr (1985); 1991 May; 142(4):307-11. PubMed ID: 1719625
    [Abstract] [Full Text] [Related]

  • 24. Coagulopathy in cytogenetically and molecularly distinct acute leukemias at diagnosis: Comprehensive study.
    Guo Z, Chen X, Tan Y, Xu Z, Xu L.
    Blood Cells Mol Dis; 2020 Mar; 81():102393. PubMed ID: 31918382
    [Abstract] [Full Text] [Related]

  • 25. Disseminated intravascular coagulation score evolution in 48 h predicts early death in acute promyelocytic leukemia patients.
    Infante JB, Esteves GV, Raposo J, de Lacerda JF.
    Eur J Haematol; 2024 May; 112(5):840-844. PubMed ID: 38305491
    [Abstract] [Full Text] [Related]

  • 26. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score.
    Dempfle CE, Wurst M, Smolinski M, Lorenz S, Osika A, Olenik D, Fiedler F, Borggrefe M.
    Thromb Haemost; 2004 Apr; 91(4):812-8. PubMed ID: 15045145
    [Abstract] [Full Text] [Related]

  • 27. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
    Rodríguez Gómez M, López Fernández MF, Batlle J.
    Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
    [Abstract] [Full Text] [Related]

  • 28. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
    Chang H, Kuo MC, Shih LY, Dunn P, Wang PN, Wu JH, Lin TL, Hung YS, Tang TC.
    Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
    [Abstract] [Full Text] [Related]

  • 29. Circulating levels of DNA-histone complex and dsDNA are independent prognostic factors of disseminated intravascular coagulation.
    Kim JE, Lee N, Gu JY, Yoo HJ, Kim HK.
    Thromb Res; 2015 Jun; 135(6):1064-9. PubMed ID: 25843168
    [Abstract] [Full Text] [Related]

  • 30. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
    Kim SY, Kim JE, Kim HK, Kim I, Yoon SS, Park S.
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):150-6. PubMed ID: 23314386
    [Abstract] [Full Text] [Related]

  • 31. Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia.
    Higuchi T, Shimizu T, Mori H, Niikura H, Omine M.
    Hematol Oncol; 1997 Nov; 15(4):209-17. PubMed ID: 9722892
    [Abstract] [Full Text] [Related]

  • 32. [Intravascular coagulation in acute promyelocytic leukemia: analysis of coagulation and fibrinolysis parameters].
    Chuecas F, Loredo E, Muñoz B, Alfaro J, Grebe G, Lira P.
    Rev Med Chil; 1991 Sep; 119(9):984-9. PubMed ID: 1845106
    [Abstract] [Full Text] [Related]

  • 33. D-dimer test: diagnostic role in clinical and sub-clinical DIC.
    Saxena R, Gupta PK, Ahmed R, Batra V, Kumar S.
    Indian J Pathol Microbiol; 2003 Jul; 46(3):425-6. PubMed ID: 15025290
    [Abstract] [Full Text] [Related]

  • 34. Rapid improvement of coagulopathy by all-trans retinoic acid in acute promyelocytic leukemia.
    Kawai Y, Watanabe K, Kizaki M, Murata M, Kamata T, Uchida H, Moriki T, Yokoyama K, Tokuhira M, Nakajima H.
    Am J Hematol; 1994 Jul; 46(3):184-8. PubMed ID: 8192147
    [Abstract] [Full Text] [Related]

  • 35. [Acute renal failure in a patient with disseminated intravascular coagulation accompanied by acute promyelocytic leukemia: a case report, diagnostic difficulties].
    Chudek J, Kopera M, Kokot F, Nieszporek T, Witkowicz J, Hołowiecki J.
    Przegl Lek; 2002 Jul; 59(1):61-2. PubMed ID: 12108050
    [Abstract] [Full Text] [Related]

  • 36. Disseminated Intravascular Coagulation in Acute Promyelocytic Leukemia Patients: A Retrospective Analysis of Outcomes and Healthcare Burden in US Hospitals.
    Patel R, Patel D, Patel M, Ohemeng-Dapaah J, Onyechi A, Patel Z, Yang C, Shaikh S.
    Turk J Haematol; 2024 Mar 01; 41(1):1-8. PubMed ID: 38374587
    [Abstract] [Full Text] [Related]

  • 37. Utility of the fibrinogen/C-reactive protein ratio for the diagnosis of disseminated intravascular coagulation.
    Kim HK, Lee DS, Kang SH, Kim JQ, Park S, Cho HI.
    Acta Haematol; 2007 Mar 01; 117(1):34-9. PubMed ID: 17095857
    [Abstract] [Full Text] [Related]

  • 38. Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.
    Ookura M, Hosono N, Tasaki T, Oiwa K, Fujita K, Ito K, Lee S, Matsuda Y, Morita M, Tai K, Negoro E, Kishi S, Iwasaki H, Ueda T, Yamauchi T.
    Medicine (Baltimore); 2018 Nov 01; 97(44):e12981. PubMed ID: 30383650
    [Abstract] [Full Text] [Related]

  • 39. The value of FDP/FIB and D-dimer/FIB ratios in predicting high-risk APL-related thrombosis.
    Bai Y, Shi M, Yang X, Zhang W, Yang R, Wei X, Wei X, Duan L, Wang C, Mi R, Waqas Ahmed HA, Huo L, Chen Y, Xu F, Wu D, Sun K.
    Leuk Res; 2019 Apr 01; 79():34-37. PubMed ID: 30831481
    [Abstract] [Full Text] [Related]

  • 40. Predictive factors for differentiating thrombohemorrhagic disorders in high-risk acute promyelocytic leukemia.
    Xiao M, Zhou P, Liu Y, Wei S, Li D, Li W, Niu X, Niu J, Zhang Y, Cao W, Liu B, Wang X, Bai Y, Sun K.
    Thromb Res; 2022 Feb 01; 210():33-41. PubMed ID: 34998209
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.